Page last updated: 2024-08-23

paclitaxel and Deafness, Transitory

paclitaxel has been researched along with Deafness, Transitory in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Casale, M; Di Peco, V; Firrisi, L; Greco, F; Onori, N; Salvinelli, F; Santini, D; Tonini, G; Vincenzi, B	1

Other Studies

1 other study(ies) available for paclitaxel and Deafness, Transitory

Article	Year
Bilateral irreversible hearing loss associated with the combination of carboplatin and paclitaxel chemotherapy: a unusual side effect. Journal of experimental & clinical cancer research : CR, 2003, Volume: 22, Issue:1 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Audiometry; Carboplatin; Female; Hearing Loss; Humans; Neoplasm Staging; Ovarian Neoplasms; Paclitaxel; Time Factors; Treatment Outcome	2003

Article

Year

Bilateral irreversible hearing loss associated with the combination of carboplatin and paclitaxel chemotherapy: a unusual side effect.

Journal of experimental & clinical cancer research : CR, 2003, Volume: 22, Issue:1

Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Audiometry; Carboplatin; Female; Hearing Loss; Humans; Neoplasm Staging; Ovarian Neoplasms; Paclitaxel; Time Factors; Treatment Outcome

2003